Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 10 February 1989:
Vol. 243. no. 4892, pp. 811 - 814
DOI: 10.1126/science.2916128

Articles

Science, Vol 243, Issue 4892, 811-814
Copyright © 1989 by American Association for the Advancement of Science


articles

Overexpression of transforming growth factor alpha in psoriatic epidermis

JT Elder, GJ Fisher, PB Lindquist, GL Bennett, MR Pittelkow, RJ Coffey Jr, L Ellingsworth, R Derynck, and JJ Voorhees

Department of Dermatology, University of Michigan, Ann Arbor 48109.

Transforming growth factor alpha (TGF-alpha) is produced by and required for the growth of epithelial cells and is angiogenic in vivo. Since epidermal hyperplasia and angiogenesis are hallmarks of psoriasis, TGF-alpha gene expression was analyzed in epidermal biopsies of normal and psoriatic skin. TGF-alpha messenger RNA and protein are much more abundant in lesional psoriatic epidermis than in normal-appearing skin of psoriatic patients or in normal epidermis. In contrast, messenger RNA levels of transforming growth factor beta 1 (TGF-beta 1), which inhibits epithelial cell growth, are not significantly different in normal, uninvolved, and lesional psoriatic epidermis. Thus, psoriatic epidermal hyperplasia may involve increased expression of a keratinocyte mitogen (TGF-alpha) rather than deficient expression of a growth inhibitor (TGF-beta 1).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology.
M. R. Schneider, S. Werner, R. Paus, and E. Wolf (2008)
Am. J. Pathol. 173, 14-24
   Abstract »    Full Text »    PDF »
7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a Benzodiazepine, Suppresses Keratinocyte Proliferation and Has Antipsoriatic Activity in the Human Skin-Severe, Combined Immunodeficient Mouse Transplant Model.
N. Bhagavathula, K. C. Nerusu, A. Hanosh, M. N. Aslam, T. B. Sundberg, A. W. Opipari Jr., K. Johnson, S. Kang, G. D. Glick, and J. Varani (2008)
J. Pharmacol. Exp. Ther. 324, 938-947
   Abstract »    Full Text »    PDF »
Differential ErbB1 Signaling in Squamous Cell versus Basal Cell Carcinoma of the Skin.
L. Rittie, S. Kansra, S. W. Stoll, Y. Li, J. E. Gudjonsson, Y. Shao, L. E. Michael, G. J. Fisher, T. M. Johnson, and J. T. Elder (2007)
Am. J. Pathol. 170, 2089-2099
   Abstract »    Full Text »    PDF »
Srcasm Corrects Fyn-induced Epidermal Hyperplasia by Kinase Down-regulation.
W. Li, C. Marshall, L. Mei, J. Gelfand, and J. T. Seykora (2007)
J. Biol. Chem. 282, 1161-1169
   Abstract »    Full Text »    PDF »
BP-1107 [{2-[4-(2,4-Dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: A Novel Synthetic Thiazolidinedione That Inhibits Epidermal Hyperplasia in Psoriatic Skin-Severe-Combined Immunodeficient Mouse Transplants after Topical Application.
N. Bhagavathula, K. C. Nerusu, M. Reddy, C. N. Ellis, A. Chittiboyina, M. Avery, H. A. Pershadsingh, T. W. Kurtz, and J. Varani (2005)
J. Pharmacol. Exp. Ther. 315, 996-1004
   Abstract »    Full Text »    PDF »
Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-37.
S. Tokumaru, K. Sayama, Y. Shirakata, H. Komatsuzawa, K. Ouhara, Y. Hanakawa, Y. Yahata, X. Dai, M. Tohyama, H. Nagai, et al. (2005)
J. Immunol. 175, 4662-4668
   Abstract »    Full Text »    PDF »
Psoriasis.
M. P. Schön and W.-H. Boehncke (2005)
N. Engl. J. Med. 352, 1899-1912
   Full Text »    PDF »
A Novel Benzodiazepine Selectively Inhibits Keratinocyte Proliferation and Reduces Retinoid-Induced Epidermal Hyperplasia in Organ-Cultured Human Skin.
J. Varani, N. Bhagavathula, K. C. Nerusu, H. Sherzer, K. Fay, A. E. Boitano, G. D. Glick, K. Johnson, S. Kang, and A. W. Opipari Jr. (2005)
J. Pharmacol. Exp. Ther. 313, 56-63
   Abstract »    Full Text »    PDF »
Amphiregulin and Epidermal Hyperplasia: Amphiregulin Is Required to Maintain the Psoriatic Phenotype of Human Skin Grafts on Severe Combined Immunodeficient Mice.
N. Bhagavathula, K. C. Nerusu, G. J. Fisher, G. Liu, A. B. Thakur, L. Gemmell, S. Kumar, Z. H. Xu, P. Hinton, N. Tsurushita, et al. (2005)
Am. J. Pathol. 166, 1009-1016
   Abstract »    Full Text »    PDF »
Autocrine Extracellular Signal-regulated Kinase (ERK) Activation in Normal Human Keratinocytes: Metalloproteinase-mediated Release of Amphiregulin Triggers Signaling from ErbB1 to ERK.
S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder (2004)
Mol. Biol. Cell 15, 4299-4309
   Abstract »    Full Text »    PDF »
Induction of Disease-associated Keratin 16 Gene Expression by Epidermal Growth Factor Is Regulated through Cooperation of Transcription Factors Sp1 and c-Jun.
Y.-N. Wang and W.-C. Chang (2003)
J. Biol. Chem. 278, 45848-45857
   Abstract »    Full Text »    PDF »
Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation.
F. Mascia, V. Mariani, G. Girolomoni, and S. Pastore (2003)
Am. J. Pathol. 163, 303-312
   Abstract »    Full Text »    PDF »
Wound Healing and Expression of Antimicrobial Peptides/Polypeptides in Human Keratinocytes, a Consequence of Common Growth Factors.
O. E. Sorensen, J. B. Cowland, K. Theilgaard-Monch, L. Liu, T. Ganz, and N. Borregaard (2003)
J. Immunol. 170, 5583-5589
   Abstract »    Full Text »    PDF »
1,25-Dihydroxyvitamin D Down-regulates Cell Membrane Growth- and Nuclear Growth-promoting Signals by the Epidermal Growth Factor Receptor.
J. B. Cordero, M. Cozzolino, Y. Lu, M. Vidal, E. Slatopolsky, P. D. Stahl, M. A. Barbieri, and A. Dusso (2002)
J. Biol. Chem. 277, 38965-38971
   Abstract »    Full Text »    PDF »
Metalloproteinases Stimulate ErbB-dependent ERK Signaling in Human Skin Organ Culture.
S. W. Stoll, S. Kansra, and J. T. Elder (2002)
J. Biol. Chem. 277, 26839-26845
   Abstract »    Full Text »    PDF »
Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor.
D. Creamer, M. Allen, R. Jaggar, R. Stevens, R. Bicknell, and J. Barker (2002)
Arch Dermatol 138, 791-796
   Abstract »    Full Text »    PDF »
Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. I. Differential Regulation of Lipopolysaccharide-Mediated Proinflammatory Cytokine (Interleukin-6 and Tumor Necrosis Factor-alpha ) Biosynthesis in Alveolar Epithelial Cells.
J. J. Haddad, S. C. Land, W. O. Tarnow-Mordi, M. Zembala, D. Kowalczyk, and R. Lauterbach (2002)
J. Pharmacol. Exp. Ther. 300, 559-566
   Abstract »    Full Text »    PDF »
Matrix-independent Survival of Human Keratinocytes through an EGF Receptor/MAPK-Kinase-dependent Pathway.
M. Jost, T. M. Huggett, C. Kari, and U. Rodeck (2001)
Mol. Biol. Cell 12, 1519-1527
   Abstract »    Full Text »
Clastogenic effects of two tyrosine kinase inhibitors, Tyrphostin 23 and Tyrphostin 46, on a transformed (CHO-K1) and on a primary embryonic Chinese hamster cell line (CHE).
L. Bassi, R. Buzzi, M. Fiore, and F. Palitti (2000)
Mutagenesis 15, 341-347
   Abstract »    Full Text »    PDF »
Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes.
Y. Shirakata, T. Komurasaki, H. Toyoda, Y. Hanakawa, K. Yamasaki, S. Tokumaru, K. Sayama, and K. Hashimoto (2000)
J. Biol. Chem. 275, 5748-5753
   Abstract »    Full Text »    PDF »
Essential Role of Mitogen-Activated Protein Kinase Pathway and c-Jun Induction in Epidermal Growth Factor-Induced Gene Expression of Human 12-Lipoxygenase.
B.-K. Chen, H.-C. Kung, T.-Y. Tsai, and W.-C. Chang (2000)
Mol. Pharmacol. 57, 153-161
   Abstract »    Full Text »
Regulation of Cyclooxygenase-2 by Interferon gamma and Transforming Growth Factor alpha in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells. ROLE OF MITOGEN-ACTIVATED PROTEIN KINASES.
H. Matsuura, M. Sakaue, K. Subbaramaiah, H. Kamitani, T. E. Eling, A. J. Dannenberg, T. Tanabe, H. Inoue, J. Arata, and A. M. Jetten (1999)
J. Biol. Chem. 274, 29138-29148
   Abstract »    Full Text »    PDF »
Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors.
D. R. Germolec, J. Spalding, H.-S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida, et al. (1998)
Am. J. Pathol. 153, 1775-1785
   Abstract »    Full Text »    PDF »
Human Keratinocytes Express Cellular Prion-Related Protein in Vitro and during Inflammatory Skin Diseases.
J. Pammer, W. Weninger, and E. Tschachler (1998)
Am. J. Pathol. 153, 1353-1358
   Abstract »    Full Text »    PDF »
In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor.
R. L. Panek, G. H. Lu, S. R. Klutchko, B. L. Batley, T. K. Dahring, J. M. Hamby, H. Hallak, A. M. Doherty, and J. A. Keiser (1997)
J. Pharmacol. Exp. Ther. 283, 1433-1444
   Abstract »    Full Text »
.
T. K. Dahring, G. H. Lu, J. M. Hamby, B. L. Batley, A. J. Kraker, and R. L. Panek (1997)
J. Pharmacol. Exp. Ther. 281, 1446-1456
   Abstract »
Cysteines 153 and 154 of Transmembrane Transforming Growth Factor-alpha Are Palmitoylated and Mediate Cytoplasmic Protein Association.
L. Shum, C. W. Turck, and R. Derynck (1996)
J. Biol. Chem. 271, 28502-28508
   Abstract »    Full Text »    PDF »
Keratinocyte Growth Factor Induces Granulation Tissue in Ischemic Dermal Wounds: Importance of Epithelial-Mesenchymal Cell Interactions.
L. Wu, G. F. Pierce, R. D. Galiano, and T. A. Mustoe (1996)
Arch Surg 131, 660-666
   Abstract »    PDF »
Transforming Growth Factor Alpha Gene Expression in Cultured Human Keratinocytes Is Unaffected by Cellular Aging.
C. C. Compton, Y. Tong, N. Trookman, H. Zhao, D. Roy, and W. Press (1995)
Arch Dermatol 131, 683-690
   Abstract »    PDF »
Tyrosine kinase inhibition: an approach to drug development.
A Levitzki and A Gazit (1995)
Science 267, 1782-1788
   Abstract »    PDF »
Cutaneous Leukocyte Trafficking and Psoriasis.
C. E. M. Griffiths (1994)
Arch Dermatol 130, 494-499
   Abstract »    PDF »
Transgenic Models of Skin Diseases.
J. A. Rothnagel, D. A. Greenhalgh, X.-J. Wang, K. Sellheyer, J. R. Bickenbach, A. M. Dominey, and D. R. Roop (1993)
Arch Dermatol 129, 1430-1436
   Abstract »    PDF »
Autocrine Secretion--10 Years Later.
M. B. Sporn and A. B. Roberts (1992)
Ann Intern Med 117, 408-414
   Abstract »    PDF »
Transforming Growth Factor {alpha} Expression Helps to Distinguish Keratoacanthomas From Squamous Cell Carcinomas.
T. Ho, T. Horn, and E. Finzi (1991)
Arch Dermatol 127, 1167-1171
   Abstract »    PDF »
Cyclosporine in Psoriasis Treatment: Inhibition of Keratinocyte Cell-Cycle Progression in G1 Independent of Effects on Transforming Growth Factor {alpha}/Epidermal Growth Factor Receptor Pathways.
L. Khandke, J. F. Krane, R. Ashinoff, L. Staiano-Coico, A. Granelli-Piperno, A. D. Luster, D. M. Carter, J. G. Krueger, and A. B. Gottlieb (1991)
Arch Dermatol 127, 1172-1179
   Abstract »    PDF »
Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation..
R Vassar and E Fuchs (1991)
Genes & Dev. 5, 714-727
   Abstract »    PDF »
c-Ha-ras and UV Photocarcinogenesis: Do Rays Raise ras?.
J. T. Elder (1990)
Arch Dermatol 126, 379-382
   Abstract »    PDF »
Cyclosporine Inhibits Basic Fibroblast Growth Factor-Driven Proliferation of Human Endothelial Cells and Keratinocytes.
R. J. Sharpe, K. A. Arndt, S. I. Bauer, and T. E. Maione (1989)
Arch Dermatol 125, 1359-1362
   Abstract »    PDF »
Growth Factors: Their Biology and Promise in Dermatologic Diseases and Tissue Repair.
M. Rothe and V. Falanga (1989)
Arch Dermatol 125, 1390-1398
   Abstract »    PDF »
A Morphometric and Histologic Study of the Scalp in Psoriasis: Paradoxical Sebaceous Gland Atrophy and Decreased Hair Shaft Diameters Without Alopecia.
J. T. Headington, A. K. Gupta, M. T. Goldfarb, B. J. Nickoloff, T. A. Hamilton, C. N. Ellis, and J. J. Voorhees (1989)
Arch Dermatol 125, 639-642
   Abstract »    PDF »
Cloning and Biological Activity of Epigen, a Novel Member of the Epidermal Growth Factor Superfamily.
L. Strachan, J. G. Murison, R. L. Prestidge, M. A. Sleeman, J. D. Watson, and K. D. Kumble (2001)
J. Biol. Chem. 276, 18265-18271
   Abstract »    Full Text »    PDF »
Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase.
B.-K. Chen and W.-C. Chang (2000)
PNAS 97, 10406-10411
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)